1.- Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary
antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276:
7806?7810.
2.- Hunter HN, Fulton DB,
Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone
with antimicrobial activity that is involved in iron uptake and hereditary
hemochromatosis. J Biol Chem
2002; 277: 37597?37603.
3.- Ganz T. Hepcidin, a key regulator of iron
metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788.
4.- Valore EV, Ganz T.
Posttranslational processing of hepcidin in human hepatocytes is mediated by
the prohormone convertase furin. Blood Cells Mol Dis 2008; 40 (1): 132-138.
5.- Pandur E, Nagy J, Po?r
VS, Sarnyai A, Husz?r A, Miseta A, Sipos K. "Alpha-1 antitrypsin binds preprohepcidin
intracellularly and prohepcidin in the serum".FEBS J 2009;276(7): 2012?2021.
6.- Giuliani RA.
Hepcidina, hierro, hipoxia e inflamación. Hematología 2012; 16 (2): 100-105.
7.- Kulaksiz H,
Theiligl F, Bachmann S, Gehrke S, Rost D, Janetzko A, Cetin Y, Stremme W. The
iron-regulatory peptide hormone hepcidin: expression and cellular localization
in the mammalian kidney. Journal of Endocrinology 2005; 184: 361?370.
8.- Schwarz P,K?bler JA,Strnad P,Méller K,Barth TF,Gerloff A,Feick P, Peyssonnaux C,Vaulont S,Adler G,Kulaksiz H. Hepcidin is localised in gastric parietal
cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut 2012; 61(2): 193-201.
9.- Urruita P, Aguirre P, Sparza A, Tapia U, Mena NP. Inflammation alters expression of DMT1,
FPN1 and hepcidin, and it causes iron accumulation in central nervous system
cells. J Neurochem 2013; 126: 541-549.
10.- Audin S, Celik O, Gurates B, Ulas M, Yilmaz M, Kalayci M,
Kuloglut T, Cataz Z, Ozercau JH, Kumru S. Concentrations of preptin, salusin
and hepcidin in plasma and milk of lactating women with and without gestational
diabetes mellitus. Peptides2013; 49: 123-130.
11.- Meynard D,
Babbitt JL, Lin HY. The liver: conductor of systemic iron balance. Blood 2014;
123:168-176.
12.- Fung E, Nemeth E. Manipulation of the hepcidin
pathway for therapeutic purposes. Haematologica 2013; 98: 1667-1676.
13.- Pigeon C, Ilyng G,
Courselanud B. A new mouse liver-specific gene encoding a protein homologous to
human antimicrobial peptide hepcidin, is overexpressed during iron overload. J
Biol Chem 2001; 276: 7811-8919.
14.- Nicolas G, Bennoun M,
Devaux I , Beaumont C, Grandchamp B, Kahn A, Vaulont S. Lack of hepcidin gene
expression and severe tissue iron overload in upstream stimulatory factor 2
(USF2) knockout mice. Proc Natl Acad Sci USA
2001; 98 (15): 8780-8785.
15.- Nicolas G, Bennoun M,
Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A,
Vaulont S. Severe iron deficiency
anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99 (7): 4596-4601.
16.- Nemeth E,
Ganz T. Regulation
of iron metabolism by hepcidin. Ann Rev Nutr
2006; 26: 323-342.
17.- Nemeth E, Tuttle MS, Powelson J, Vaughn M, Donovan
A, McVey Ward D. Hepcidin regulates cellular
iron eflux by binding to ferroportin (Fpn) and inducing its internalization.
Science 2004; 306: 2090-2093.
18.- Ward D, Kaplan J. Ferroportin-mediated iron
transport expression and regulation. Biochim Biophys Acta 2012; 1823(9):
1426-1433.
19,- Donovan A, Lima CA, Pinkus JL, Pinkus
GS, Zon LI, Robine S, Andrews NC: The iron exporter ferroportin/Slc40a1 is
essential for iron homeostasis. Cell Metab 2005; 1: 191?200.
20.- Fung E, Sugianto P, Hsu J, Damoiseaux R, Ganz T,
Nemeth E. High-throughput screening of small molecules identifies hepcidin
antagonists. Mol Pharmacol 2013; 83: 681-890.
21.- Zhao N, Zhang A, Enns C. Iron regulation
by hepcidina. J Clin Invest 2013; 123(6): 2337-2343.
22.- Chung B,
Chaston T, Marks J, Kaila S, Sharp PA. Hepcidin decreases iron transport
expression in vivo in duodenum and spleen and in vitro in THP-1 macrophages and
in intestinal Caco 2 cells. J Nutr 2009; 139: 1457-1462.
23.- Wessling-Resnick
M. Iron. En: Modern Nutrition in Health and Disease. Edición 11. Editores: Ross
C, Caballero B, Cousins RJ, Tucker KL, Ziegler TR. Lippincott Williams &
Wilkins. Baltimore MD USA 2012, pp 176-188.
24.- Nicolas G,
Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont
S. The gene encoding the iron regulatory peptide hepcidin is regulated by
anemia, hypoxia, and inflammation. J
Clin Invest 2002; 110(7):
1037-1044.
25.-
Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of
the iron exporter ferroportin at the plasma membrane of macrophages is enhanced
by iron loading and down-regulated by hepcidin. Blood 2005; 106: 3979-3984.
26.- Ganz T. Hepcidin and
its role in regulating systemic iron metabolism. Hematology 2006; 29-35.
27.- Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-4433.
28.- Sosa-Garrocho
M, Macías Silva M. El factor de crecimiento transformante Beta (TGF-?):
Funciones y vías de transducción. REB 2004;
23(I): 3-11.
29.- Goswani T, Andrews NC. Hereditary
hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests
a molecular mechanism for mammalian iron sensing. J Biol Chem 2006; 281(39): 28494-28498.
30.- Meynard D, Kautz
L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone
morphogenetic protein BMP6 induces iron overload. Nat Genet 2009; 41(4): 478-481.
31.- Andriopoulos B Jr,
Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, y col. BMP6 is a key
endogenous regulator of hepcidin expression and iron metabolism. Nat Genet
2009; 41(4): 482-487.
32.- Arndt S, Maegdefrau U, Dorn C, Schardt K, Hellerbrand
C, Bosserhoff K. Intestinal BMP6, a master gene for the regulation of iron
homeostasis. Meeting Report. Z Gastroenterol 2011; 49: A1.
33.- Seidah NG, Prat A.
The biology and therapeutic targeting of the proprotein convertasas. Nature
Drug Discovery 2012; 11: 367-383.
34.- Rhodes CJ.
Processing of the insulin molecule. En: Diabetes Mellitus: A Fundamental and
Clinical Text. Third Edition. Lippincot Williams & Wilkins. 2004, pp 29-51.
35.- Geoffrey N, Hendy H, Benett PJ, Gibbs BF, Lazure C.
Proparathyroid hormone is preferentially cleaved by the prohormone convertase
furin. Jour Biol Chem 1955; 270: 9517-9525.
36.- Pandur E, Sipos K, Grama L, Nagy J, Poor VS, Setalo
G, Miseta A, Fekete Z. Prohepcidine binds to the HAMP promoter and
autoregulates its own expression. Biochem J 2013; 451: 301-311.
37.- Peslova G, Petriak J, Kuzelova K, Hrdy I, Halada P, Kuchel PW, Soe-Lin Sh, Ponka P,
Sutack R, Becker E, Li-Hsuen H, Suryo Rahmanto Y, Richardson DR, Vyoral D.
Hepcidin the hormone of iron metabolism is bound specifically to α-2- macroglobulin in blood. Blood 2009;
113: 6225-6236.
38.- Fairbanks VF. Iron in medicine and nutrition. En: Modern
Nutrition in Health and Disease. Ninth Edition. Editores: Shils ME, Olson JA,
Shike M, Ross AC. Williams&Wilkins.
Philadelphia USA. 1999, pp 193-221.
39.- Wolf C.
Hiperpigmentación cutánea y homeostasis del hierro: Rol de la hepcidina. Rev Argent Dermatol 2007;
88: 96-104.
40.- McFarlane H, Reddy S, Adcock KJ, Adeshima A, Cooke R, Akene J.
Immunity, transferrin and survival in Kwasiorkor. Brit Med J 1970; 4: 268-273.
41.- Oppenheimer SJ. Iron and its relation to immunity and infectious
diseases. J Nutr 2001; 131: 616S-635S.
42.- Wang BH, Yu XJ, Wang D, Qi XM, Wang HP, Yang TT, Xu XH. Alterations
of trace elements (Zn,Se,Cu,Fe) and related metalloenzymes in rabbit blood
after severe trauma. J Trace Elem Med Biol 2007; 21 (2): 102-107.
43.- Weinberg ED. Infection and iron metabolism. Amer J Clin Nutr 1977;
9: 1485-1490.
44.- Besson-Fournier C, Latour Ch, Kautz L, Bertrand J, Ganz T, Roth
M-P, Coppin H. Induction of activin B inflammatory stimuli up-regulates
expression of the iron-regulatory peptide hepcidine through Smad 1/5/8
signaling. Blood 2012; 120: 431-439.
45.- Wrighting D, Andrewa N.
Interleukin-6 induces hepcidin expression through STAT3. Blood 2006;
108:3204-3209.
46.- Ganz T, Nemeth E. Iron
sequestration and anemia of inflammation. Semin Hematol
2009; 46(4): 387-393.
47.- Ruiz A, Brice?o O, Arteaga-Vizcaino M, Plumacher Z, Gonzélez M,
Quintero M. Anemia hemol?tica hereditaria y sobrecarga de hierro. VITAE.
Academia Biomédica digital 53: Enero Marzo 2013.
48.- Ke Q, Costa M. Hypoxia- induced factor
(HIF). Mol Pharmacol 2006; 70: 1469-1480.
49.- Harrison R. Structure and function of xanthine
oxidorreductase: Where are we now? Free
Radical Biol Med 2002; 33: 774-797.
50.-
Ramirez-Cheyne J, Zarante I. Deficiencia de glucosa-6-fosfato deshidrogenasa.
Situación actual, su relación con malaria y estrategias para calcular su
prevalencia. Univ Med Bogot?
2009; 50(1): 58-76.
51.- Gagliardo B, Kubat N, Faye A, Jaouen M, Deschemin JC, Canonne-Hergaux
F, Sari MA, Vaulont S. Pro-hepcidin is unable to degrade the iron exporter
ferroportin unless maturated by a furin-dependent process. J Hepatol 2009;
50(2): 394-401.
52.- Guillemot J, Canuel M, Essalmani R, Prat A, Seidah NG. Implication
of the proprotein convertases in iron homeostasis proprotein convertase 7 sheds
human transferrin receptor 1 and furin activates hepcidin. Hepatology. 2013;
57(6): 2514-2524.
53.- Hyuang-Keun K, Eun-Chul J, Ju-Ok Y,
Sun-Youg K, Hyunjuns- Ch, Sung-Soo K, Hiun-Suk Ch, Young-Seok Ch. Serum
prohepcidin levels are lower in patients with atrophic gastritis. Gastroenterol
Res and Pract 2013; 201810-201816.
54.- Ozcasap S, Yarali N, Isik P, Kava A,
Tune B. The role of prohepcidin in anemia due to Helicobacter pylori infection. Pediatr Hematol Oncol 2013; 30: 425-
431.
55.- Przbyszewska J, Zekanowska E,
Kedziora J, Kornatowka K, Boinska J, Pozynch K, Przybyszewski M, Cichon R.
Comparison of serum prohepcidin and iron metabolism parameters in obese and non
obese elderly individuals. Endokrynol Pol 2013; 64: 272-277.
56.- Kouiche H, Hirofumi U, Nobuchito O,
Tokinaga M, Utsonomiya A, Handa Sh, Hiroito T. Serum prohepcidin levels are
potential prognostic markers in patients with multiple mieloma. Experimental
Therapeutic Medicine 2012; 4: 581-588.
57.- Przbyszewska J, Zekanowska E,
Kedziora-Kornatowska K, Boinska J, Cichon R, Porzych K. Serum prohepcidin and
other iron metabolism parameters in anemia of chronic disease and with iron
deficiency anemia. Polskie Archivum Medycyny Wewnetrznej 2013; 123:105- 110.
58.-
Caliskan Y, Yelken B, Ozkok A, Gorgulu N, Yazici H, Telci A, Yildiz Z. Lower
serum prohepcidin levels associated with lower iron and erythropoyetic
requirements in hemodylaisis patients with chronic hepatitis C. BMC Nephrol 2012;
13: 56-63.
59.- Barrios Y, Espinoza M, Baron MA. Prohepcidina, su relación
con indicadores del metabolismo del hierro y de inflamación en pacientes
hemodializados tratados o no con eritropoyetina recombinante. Nutr Hospit 2010; 25: 555-560.
60.- Murphy AT, Witcher DR, Luan P, Wroblewski VS. Quantitation
of hepcidin from human and mouse serum using liquid chromatography tandem mass
spectrometry. Blood 2007; 110: 1048-1054.
61.-
Dudkowiak R, Neubauer K, Poniewierka E. Hepcidin and its role in inflamatory
bowel diseases. Adv Clin Exp Med 2013; 22: 585-591.
62.-
Oustamanolakis P, Koutrabakis IE, Kouroumalis EA. Diagnosing anemia in
inflamatory bowel disease: beyond the established markers. J Crohns Colitis
2010; 5: 381-391.
63.-
Oustamanolakis P, Koutroubakis IE, Messaritakis N, Malliaraki N, Sfiridakis A,
Kouromalis EA. Serum hepcidin and prohepcidin concentration in inflammatory
bowel disease. (8o Congress of European Crohnís and Colitis Organization Poster
P085. Viena Austria Feb 14-16, 2013.
64.-
Bunn HF. Eritropoietin. Cold Spring Harb Perspect Med 2013; 3: a011619.
65.- Drysdale JW, Munro HN. Regulation of
synthesis and turnover of ferritin in rat liver. Journ Biol Chem 1966;
241: 3630-3637.
66.- Wallander ML, Leibold EA, Eisenstein
RS. Molecular control of vertebrate iron homeostasis by iron regulatory
proteins Biochem Biophys Acta 2006; 1763: 668-689.
67.- Beinert H, Kennedy MC. Aconitase, a
two faced protein: enzyme and iron regulatory factor. FASEB
J 1993; 7: 1442-1449.
68.- Iron en Dietary Reference Intakes.
Institute of Medicine.Panel on Micronutrients. National Academy
Press. Washignton DC 2001.
69.- Frazer DM, Anderson GJ. I. Intestinal
iron absorption and its regulation. Am J Physiol, Gastrointestinal Liver
Physiol 2005; 289: G631-G635.
70.- Wood RJ, Ronnenberg AG. Iron. En: Modern Nutrition
in Health and Disease. Tenth Edition. Shils ME, Shike M, Ross AC, Caballero B,
Cousin RJ (Editores). Lippincott
Williams y Wilkins. Baltimore MD. 2006, pp 248-270.
71.- Laufberger V. Sur la cristallisation de la ferritine.
Bulletin de la Societe de chimie biologique 1937; 19: 1575-1582.
72.-
Cannone-Hergaux F, Gruenheid S, Ponka P, Gros P. Cellular and subcellular
localization of Nramp2 iron transporter in the intestinal brush border and
regulation by dietary iron. Blood 1999; 93: 4406-4417.
73.-
Cartwright GE, Lauritsen MA, Jones PJ, Merril IM, Wintrobe MM. The anemia of
infection. I Hypoferremia, hypercupremia and alterations in porphyrin
metabolism in patients. JCI 1946; 25: 65-68.
74.-
Cartwright GE, Lauritsen MA, Humphrey S, Jones PJ, Merrill IM, Wintrobe MM. The
anemia of infection. II The experimental production of the hipoferremia and
anemia in dogs. JCI 1946; 25: 81-86.
75.-
Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by
rat hepatoma cells and its regulation by inflammatory cytokines. Blood 1997;
90: 4979-4986.
76.-
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum Ferritin: Past
present and future. Biochem Biophys Acta 2010; 1800: 760-769.
77.-
Barton CH, Biggs TE, Baker ST, Bowen H, Atkinson PG. Nramp1: a link between
intracelular iron transport and innate resistance to intracelular pathogens. Journal
of Leucocytes Biology 1999; 66: 757-762.
78.-
Zwilling BS, Kuhn DE, Wikoff L, Brown D, Lafuse W. Role of iron in
Nramp1-mediated inhibition of mycobacterial growth. Infect Immun 1999; 67:
1386-1382.
79.-
WHO. Worldwide prevalence of Vitamin A deficiencies in populations at risk
1995-2005. WHO global database on vitamin A deficiency. Geneva World Health
Organization 2006.
80.-
WHO, CDC. Worldwide prevalence of anemia 1993-2005. WHO Global database on
anemia. Geneva. World Health Organization 2006.
81.-
WHO Global database on Iodine deficiency. World Health Organization 2007.
82.-
Iron. En: Dietary Reference Intakes for: Vitamin A, Vitamin K, Arsenic, Boron,
Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon,
Vanadium and Zinc. Food and Nutrition Board. Institute of Medicine. National
Academy Press.Washington DC 2002.